BioSpace News Archive

Champions Oncology, Inc. (NASDAQ:CSBR) a leading global oncology technology solutions provider transforming drug discovery through innovative pharmacology, biomarker, and data platforms, is pleased to announce the appointment of Rob Brainin to its Board of Directors.

In a recent announcement by Rutgers Cancer Institute of New Jersey and the Center for Applied Proteomics and Molecular Medicine at George Mason University (CAPMM), Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”), was named commercial provider of its patented Reverse Phase Protein Array (RPPA) technology for breast cancer patients, if the proposed study has a positive outcome.

Premier Health of America Inc. (TSXV: PHA) (“Premier Health” or the “Corporation”), a leading Canadian Healthtech company, is pleased to announce that it has closed its previously announced bought deal prospectus offering of 7,130,000 common shares of the Corporation at a price of $1.05 per share (the “Offering Price”) for gross proceeds of $7,486,500 (the “Offering”)

EnPro Industries, Inc. (NYSE: NPO) will present at J.P. Morgan Global High Yield & Leveraged Finance Conference on Tuesday, March 2.

Wugen Inc., a biotechnology company developing novel, universal allogeneic off-the-shelf cell therapies, today announced the appointment of Jan Davidson M.D., Ph.D., as the company’s Chief Medical Officer (CMO).

EV Biologics Corp, (OTC PINK:YECO), today announced that during its Q1 R&D meeting, the executive board reviewed and has approved a plan for cGMP process development and scalable biomanufacturing of exosome biopharmaceuticals. EV Biologics has designed a modular process for production of extracellular vesicles (EVs) with native therapeutic properties, beginning with optimized producer cells.

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis, Alzheimer’s Disease and other neurodegenerative diseases, has joined forces with the National Organization for Rare Disorders to help raise awareness for this year’s Rare Disease Day® on February 28th.

Target RWE, a leading real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries, announced newest data from its ongoing nonalcoholic steatohepatitis (NASH) observational study, published in Hepatology Communications (https://doi.org/10.1002/hep4.1689).

Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, and Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference

Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-man clinical use of the only FDA cleared cold storage device for donor lungs, its LUNGguard™ Donor Lung Preservation System, by Duke University Hospital.